Xarelto 15 mg, Filmtabletten - 98 Tablette(n) Swissmedic Key 58728012 Registration Holder Bayer (Schweiz) AG Name Xarelto 15 mg, Filmtabletten Date of registration 18.12.2008 Original/Generic Original Introduction of Sequence 04.04.2012 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 06.03.40. Show package size 98 Tablette(n) Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 207.01 Limitation Yes Limitation text
Deductible 10 % Consumer price 233.10 Feedback FB Daily cost GTIN 7680587280120 Medication Code Synthetika Pharmacode 5249661 Disponibility
Composition rivaroxabanum 15 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, lactosum monohydricum 25.4 mg, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 3350, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 0.6 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Rivaroxabanum 15 mg
BAG: Active Agent Dose Rivaroxabanum 15 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hypromellosum Überzug Lactose Monohydrate 25.4 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Pro Compresso Obducto
Source Data was imported : 14.04.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
